Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COL-3 in HIV-related Kaposi's Sarcoma
NCT00020683Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 2003
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of incyclinide in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Started Mar 2003; status: terminated.
02
Drugs
incyclinide
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00020683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020683.